Chronic regulation of arterial blood pressure by ANP: Role of endogenous vasoactive endothelial factors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 44, Issue 5, 1998, Pages

  Melo, L G ^a   Veress, A T ^a   Ackermann, U ^a   Sonnenberg, H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

C type natriuretic peptide; Endothelin; Endothelium; Nitric oxide

Indexed keywords

EID: 33750716591     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Anand-Srivastava, M. B., M. R. Sairain, and M. Cantin. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. J. Biol. Chem. 265: 8566-8572, 1990.
2. Anand-Srivastava, M. B., and G. J. Trachte. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45: 455-497, 1993.
3. Barbee, R. W., B. D. Perry, R. N. Re, J. P. Murgo, and L. J. Field. Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor. Circ. Res. 74: 747-751, 1994.
4. Bolger, G., F. Liard, R. Krogsrud, E. Weichner, and J. Jaramillo. Interactions between endothelin and atrial natriuretic factor in the rat aortic ring preparation. Can. J. Physiol. Pharmacol. 69: 1155-1162, 1991.
5. Brandt, R. R., D. M. Heublein, L. L. Aahus, J. A. Lewicki, and J. C. Burnett, Jr. Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H326-H331, 1995.
6. Bredt, D. S., and S. H. Snyder. Isolation of nitric oxide synthethase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682-685, 1990.
7. Budzik, G. P., S. L. Firestone, E. N. Bush, P. J. Connolly, T. W. Rockway, V. K. Sarin, and W. H. Holleman. Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypes. Biochem. Biophys. Res. Commun. 144: 422-431, 1987.
8. Charles, C. J., E. A. Espiner, and A. M. Richards. Cardiovascular actions of ANF: contributions of renal, neurohumoral, and hemodynamic factors in sheep. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R533-R538, 1993.
9. De Leon, H., M.-C. Bonhomme, G. Thibault, and R. Garcia. Localization of atrial natriuretic factor receptors in the mesenteric arterial bed: comparisons with angiotensin II and endothelin receptors. Circ. Res. 77: 64-72, 1995.
10. Douglas, S. A., R. M. Edwards, J. D. Elliot, and E. H. Ohlstein. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB-209670. Br. J. Pharmacol. 114: 405-413, 1995.
11. Drewett, J. G., B. M. Fendly, D. L. Garbers, and D. G. Lowe. Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of pre-contracted rat aorta. J. Biol. Chem. 270: 4668-4674, 1995.
12. Eguchi, S., Y. Hirata, T. Imai, K. Kanno, and F. Marumo. Phenotypic changes of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 134: 222-228, 1994.
13. Emori, T., Y. Hirata, T. Imai, S. Eguchi, K. Kanno, and F. Marumo. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 133: 2474-2480, 1993.
14. Faber, J. E. Lack of an effect of atrial natriuretic peptide on myogenic contraction of microvascular smooth muscle. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H419-H423, 1990.
15. Firth, J. D., and P. J. Ratcliffe. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischaemia on renal gene expression. J. Clin. Invest. 90: 1023-1031, 1992.
16. Flowers, M. A., Y. Wang, R. J. Stewart, B. Patel, and P. A. Marsden. Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1988-H1997, 1995.
17. G-nitro-L-arginine methyl esther in conscious, Long-Evans rats. Br. J. Pharmacol. 101: 625-631, 1990.
18. Granger, J. P., T. J. Opgenorth, J. Salazar, J. C. Romero, and J. C. Burnett, Jr. Long-term hypotensive and renal effects of atrial natriuretic peptide. Hypertension 8, Suppl. II: II-112-II-116, 1986.
19. Harrison-Bernard, L. M., R. C. Vari, W. H. Holleman, N. C. Trippodo, and R. W. Barbee. Chronic vs. acute hemodynamic effects of atrial natriuretic factor in conscious rats. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R247-R254, 1991.
20. Hirata, K.-I., R. Kuroda, T. Sakoda, M. Katayama, N. Inoue, M. Suematsu, S. Kawashima, and M. Yokoyama. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25: 180-185, 1995.
21. Hu, R. M., E. R. Levin, A. Pedram, and H. J. L. Frank. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells: mediation through the C receptor. J. Biol. Chem. 267: 17384-17389, 1992.
22. Inagami, T., M. Naruse, and R. Hoover. Endothelium as an endocrine organ. Annu. Rev. Physiol. 57: 171-189, 1995.
23. John, S. W. M., J. H. Krege, P. M. Oliver, J. R. Hagaman, J. B. Hodgin, S. C. Pang, T. G. Flynn, and O. Smithies. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681, 1995.
24. Kato, J., K. L. Lanier-Smith, and M. G. Currie. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells. J. Biol. Chem. 266: 14681-14685, 1991.
25. Klabunde, R. E., M. C. Helgren, E. I. Novosad, and T. J. Opgenorth. Atrial natriuretic peptide (ANP) does not inhibit the basal vascular tone present in the in situ blood-perfused dog gracilis muscle. Life Sci. 47: 2027-2033, 1990.
26. Kohno, M., K. Yokokawa, T. Horio, K. Yasunari, K.-I. Murakawa, and T. Takeda. Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta. Circ. Res. 70: 241-247, 1992.
27. Leitman, D. C., J. W. Andresen, T. Kuno, Y. Kamisaki, J. K. Chang, and F. Murad. Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. J. Biol. Chem. 261: 11650-11655, 1986.
28. Leitman, D. C., and F. Murad. Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cells. Biochim. Biophys. Acta 885: 74-79, 1986.
29. Lopez, M. J., S. K.-F. Wong, I. Kishimoto, S. Dubois, V. Mach, J. Friesen, D. L. Garbers, and A. Beuve. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65-68, 1995.
30. MacCumber, M. W., C. A. Ross, B. M. Glaser, and S. H. Snyder. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. Natl. Acad. Sci. USA 86: 7285-7289, 1989.
31. McLay, J. S., P. K. Chatterjee, A. G. Jardine, and G. A. Hawksworth. Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect. J. Hypertens. 13: 625-630, 1995.
32. Melo, L. G., and H. Sonnenberg. Requirement for prostaglandin synthesis in secretion of atrial natriuretic factor from isolated rat heart. Regul. Pept. 60: 79-87, 1995.
33. Melo, L. G., A. T. Veress, C. K. Chong, S. C. Pang, T. G. Flynn, and H. Sonnenberg. Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R255-R261, 1998.
34. Michel, T., G. K. Li, and L. Busconi. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 90: 6252-6256, 1993.
35. Minamino, N., M. Aburaya, M. Kojima, K. Miyamoto, K. Kangawa, and H. Matsuo. Distribution of C-type natriuretic and its messenger RNA in rat central nervous system and peripheral tissue. Biochem. Biophys. Res. Commun. 197: 326-335, 1993.
36. Nazario, B., R. M. Hu, A. Pedram, B. Prins, and E. R. Levin. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J. Clin. Invest. 95: 1151-1157, 1995.
37. 125I]atrial natriuretic peptide in rat tissue: a comparative study. J. Cardiovasc. Pharmacol. 13, Suppl. 5: S67-S73, 1989.
38. Oliver, P. M., S. W. M. John, K. E. Purdy, R. Kim, N. Maeda, M. F. Goy, and O. Smithies. Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc. Natl. Acad. Sci. USA 95: 2547-2551, 1998.
39. Opgenorth, T. J., and E. I. Novosad. Atrial natriuretic factor and endothelin interactions in control of vascular tone. Eur. J. Pharmacol. 191: 351-357, 1990.
40. Osol, G., W. Halpern, B. Tesfamariam, K. Nakayama, and D. Weinberg. Synthetic atrial natriuretic factor does not dilate resistance-sized arteries. Hypertension 8: 606-610, 1986.
41. Papapetropoulos, A., N. Marczin, G. Mora, A. Milici, F. Murad, and J. D. Catravas. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents. Hypertension 26: 696-704, 1995.
42. Parkes, D. G., J. P. Coghlan, J. G. McDougall, and B. A. Scoggins. Long-term hemodynamic actions of atrial natriuretic factor (99-26) in conscious sheep. Am. J. Physiol. 254 (Heart Circ. Physiol. 23): H811-H815, 1988.
43. Pollock, J. S., M. Nakane, L. D. K Buttery, A. Martinez, D. Springall, J. M. Polak, U. Forstermann, and F. Murad. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am. J. Physiol. 265 (Cell Physiol. 34): C1379-C1387, 1993.
44. Ravichandran, L. V., and R. A. Johns. Upregulation of endothelial nitric oxide synthase expression by cyclic guanosine 3′-5′-monophosphate. FEBS Lett. 374: 295-298, 1995.
45. Sessa, W. C., J. K. Harrison, D. R. Luthin, J. S. Pollock, and K. R. Lynch. Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase. Hypertension 21: 934-938, 1993.
46. Steinhelper, M. E., K. L. Cochrane, and L. J. Field. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16: 301-307, 1990.
47. Vane, J. R., E. E. Anggard, and R. M. Hotting. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323: 27-36, 1990.
48. Veress, A. T., C. K. Chong, L. J. Field, and H. Sonnenberg. Blood pressure and fluid-electrolyte balance in ANF-trangenic mice on high- and low-salt diets. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R186-R192, 1995.
49. Wada, A., T. Tsutamoto, Y. Maeda, T. Kanamori, Y. Matsuda, and M. Kinoshita. Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1819-H1824, 1996.
50. Winquist, R. J., and T. H. Hintze. Mechanisms of atrial natriuretic factor-induced vasodilation. Pharmacol. Ther. 48: 417-426, 1990.